Yusuke Nakamura to Immunophenotyping
This is a "connection" page, showing publications Yusuke Nakamura has written about Immunophenotyping.
Connection Strength
0.056
-
A phase I clinical trial of RNF43 peptide-related immune cell therapy combined with low-dose cyclophosphamide in patients with advanced solid tumors. PLoS One. 2018; 13(1):e0187878.
Score: 0.033
-
Preapoptotic protease calpain-2 is frequently suppressed in adult T-cell leukemia. Blood. 2013 May 23; 121(21):4340-7.
Score: 0.024